Literature DB >> 33658585

High-dimensional hepatopath data analysis by machine learning for predicting HBV-related fibrosis.

Xiangke Pu1, Danni Deng2, Chaoyi Chu3, Tianle Zhou4, Jianhong Liu5.   

Abstract

Chronic HBV infection, the main cause of liver cirrhosis and hepatocellular carcinoma, has become a global health concern. Machine learning algorithms are particularly adept at analyzing medical phenomenon by capturing complex and nonlinear relationships in clinical data. Our study proposed a predictive model on the basis of 55 routine laboratory and clinical parameters by machine learning algorithms as a novel non-invasive method for liver fibrosis diagnosis. The model was further evaluated on the accuracy and rationality and proved to be highly accurate and efficient for the prediction of HBV-related fibrosis. In conclusion, we suggested a potential combination of high-dimensional clinical data and machine learning predictive algorithms for the liver fibrosis diagnosis.

Entities:  

Mesh:

Year:  2021        PMID: 33658585      PMCID: PMC7930086          DOI: 10.1038/s41598-021-84556-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  26 in total

1.  An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group.

Authors:  P Bedossa; T Poynard
Journal:  Hepatology       Date:  1996-08       Impact factor: 17.425

2.  Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.

Authors:  J J Ott; G A Stevens; J Groeger; S T Wiersma
Journal:  Vaccine       Date:  2012-01-24       Impact factor: 3.641

3.  Machine Learning and Prediction in Medicine - Beyond the Peak of Inflated Expectations.

Authors:  Jonathan H Chen; Steven M Asch
Journal:  N Engl J Med       Date:  2017-06-29       Impact factor: 91.245

4.  Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population.

Authors:  T C-F Yip; A J Ma; V W-S Wong; Y-K Tse; H L-Y Chan; P-C Yuen; G L-H Wong
Journal:  Aliment Pharmacol Ther       Date:  2017-06-06       Impact factor: 8.171

Review 5.  Global epidemiology of hepatitis B virus.

Authors:  Brian Custer; Sean D Sullivan; Thomas K Hazlet; Uchenna Iloeje; David L Veenstra; Kris V Kowdley
Journal:  J Clin Gastroenterol       Date:  2004 Nov-Dec       Impact factor: 3.062

6.  Red cell distribution width to platelet ratio for liver fibrosis: a systematic review and meta-analysis of diagnostic accuracy.

Authors:  Gerasimos P Milas; Vasilios Karageorgiou; Evangelos Cholongitas
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2019-08-12       Impact factor: 3.869

7.  Liver microRNA-29b-3p positively correlates with relative enhancement values of magnetic resonance imaging and represses liver fibrosis.

Authors:  Xijun Gong; Xiaolin Wang; Fangfang Zhou
Journal:  J Biochem       Date:  2020-12-26       Impact factor: 3.387

8.  Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis of Chronic Hepatitis B Patients in China.

Authors:  Tianyi Ren; Huan Wang; Ruihong Wu; Junqi Niu
Journal:  Gastroenterol Res Pract       Date:  2017-07-31       Impact factor: 2.260

9.  Diagnostic value of FIB-4 for liver fibrosis in patients with hepatitis B: a meta-analysis of diagnostic test.

Authors:  Zhi Yin; Jin Zou; Qiongxuan Li; Lizhang Chen
Journal:  Oncotarget       Date:  2017-04-04

10.  Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup.

Authors:  Nobuharu Tamaki; Masayuki Kurosaki; Yuka Takahashi; Yoshie Itakura; Sakura Kirino; Kento Inada; Koji Yamashita; Shuhei Sekiguchi; Yuka Hayakawa; Leona Osawa; Mayu Higuchi; Kenta Takaura; Chiaki Maeyashiki; Shun Kaneko; Yutaka Yasui; Kaoru Tsuchiya; Hiroyuki Nakanishi; Jun Itakura; Rohit Loomba; Namiki Izumi
Journal:  Int J Mol Sci       Date:  2020-12-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.